Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023
Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Research on Guillain-Barré syndrome (GBS) as a neurological adverse effect of vaccines on a global scale is scarce, highlighting the need for further investigation to evaluate its long-term impact and associated risk factors comprehensively. Hence, this study aims to assess the global burden of vaccine-associated GBS and its associated vaccines. Th...
Alternative Titles
Full title
Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f5e124bfb6b84926ac52d5f3c7a8b430
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f5e124bfb6b84926ac52d5f3c7a8b430
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-74729-2
